The expression of TNF-α-induced B lymphocyte-induced maturation protein 1 (Blimp 1) can be significantly inhibited by blocking the PI3K/Akt pathway, and thus, disturbing the PI3K/Akt pathway may be a novel approach for RA treatment. The gene discussed is PRDM1; the disease is rheumatoid arthritis.